Tong et al., 2021 - Google Patents
Lactobacillus rhamnosus GG derived extracellular vesicles modulate gut microbiota and attenuate inflammatory in DSS-induced colitis miceTong et al., 2021
View HTML- Document ID
- 10577750825194762728
- Author
- Tong L
- Zhang X
- Hao H
- Liu Q
- Zhou Z
- Liang X
- Liu T
- Gong P
- Zhang L
- Zhai Z
- Hao Y
- Yi H
- Publication year
- Publication venue
- Nutrients
External Links
Snippet
Ulcerative colitis (UC) is a relapsing and remitting inflammatory disease. Probiotics have a potential beneficial effect on the prevention of UC onset and relapse in clinical trials. Lactobacillus rhamnosus GG (L. rhamnosus GG) have shown clinical benefits on UC …
- 206010009887 Colitis 0 title abstract description 81
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Tong et al. | Lactobacillus rhamnosus GG derived extracellular vesicles modulate gut microbiota and attenuate inflammatory in DSS-induced colitis mice | |
| Jakubczyk et al. | The effectiveness of probiotics in the treatment of inflammatory bowel disease (IBD)—a critical review | |
| Astó et al. | The efficacy of probiotics, prebiotic inulin-type fructans, and synbiotics in human ulcerative colitis: a systematic review and meta-analysis | |
| Drago | Probiotics and colon cancer | |
| Liu et al. | Astaxanthin prevents alcoholic fatty liver disease by modulating mouse gut microbiota | |
| Rodriguez-Arrastia et al. | Probiotic supplements on oncology patients’ treatment-related side effects: a systematic review of randomized controlled trials | |
| Haas-Neill et al. | A budding relationship: bacterial extracellular vesicles in the microbiota-gut-brain axis | |
| Burakova et al. | The effect of short-term consumption of lactic acid bacteria on the gut microbiota in obese people | |
| Zhao et al. | High oleic acid peanut oil and extra virgin olive oil supplementation attenuate metabolic syndrome in rats by modulating the gut microbiota | |
| Xie et al. | Co-cultures of Lactobacillus acidophilus and Bacillus subtilis enhance mucosal barrier by modulating gut microbiota-derived short-chain fatty acids | |
| Lu et al. | Potential role of probiotics in ameliorating psoriasis by modulating gut microbiota in imiquimod-induced psoriasis-like mice | |
| Deng et al. | Pre-administration of berberine exerts chemopreventive effects in AOM/DSS-induced colitis-associated carcinogenesis mice via modulating inflammation and intestinal microbiota | |
| Kaźmierczak-Siedlecka et al. | Gut microbiota modulation in the context of immune-related aspects of Lactobacillus spp. and Bifidobacterium spp. in gastrointestinal cancers | |
| Poluektova et al. | The putative antidepressant mechanisms of probiotic bacteria: relevant genes and proteins | |
| Feng et al. | Heat-killed Bifidobacterium bifidum B1628 may alleviate dextran sulfate sodium-induced colitis in mice, and the anti-inflammatory effect is associated with gut microbiota modulation | |
| Niu et al. | Bifidobacterium breve alleviates DSS-induced colitis in mice by maintaining the mucosal and epithelial barriers and modulating gut microbes | |
| Biagioli et al. | Divergent effectiveness of multispecies probiotic preparations on intestinal microbiota structure depends on metabolic properties | |
| Lee et al. | Neuroprotective effects of lactobacillus plantarum PS128 in a mouse model of parkinson’s disease: The role of gut microbiota and microRNAs | |
| Marsova et al. | The Lactobacillus brevis 47 f strain protects the murine intestine from enteropathy induced by 5-fluorouracil | |
| Baek et al. | Collagen peptide exerts an anti-obesity effect by influencing the firmicutes/bacteroidetes ratio in the gut | |
| Zafar et al. | Lacticaseibacillus rhamnosus FM9 and Limosilactobacillus fermentum Y57 are as effective as statins at improving blood lipid profile in high cholesterol, high-fat diet model in male wistar rats | |
| Boicean et al. | The Importance of Microbiota and Fecal Microbiota Transplantation in Pancreatic Disorders | |
| Valadez-Bustos et al. | Oral administration of microencapsulated B. Longum BAA-999 and lycopene modulates IGF-1/IGF-1R/IGFBP3 protein expressions in a colorectal murine model | |
| Qiu et al. | GOS ameliorates nonalcoholic fatty liver disease induced by high fat and high sugar diet through lipid metabolism and intestinal microbes | |
| Ye et al. | Lactobacillus plantarum-derived postbiotics ameliorate acute alcohol-induced liver injury by protecting cells from oxidative damage, improving lipid metabolism, and regulating intestinal microbiota |